Show simple item record

dc.contributor.authorKatte, JC
dc.contributor.authorLemdjo, G
dc.contributor.authorDehayem, MY
dc.contributor.authorJones, AG
dc.contributor.authorMcDonald, TJ
dc.contributor.authorSobngwi, E
dc.contributor.authorMbanya, JC
dc.date.accessioned2022-09-27T15:19:31Z
dc.date.issued2022-01-20
dc.date.updated2022-09-27T14:32:29Z
dc.description.abstractINTRODUCTION: Type 1 diabetes in Africa has been associated with high mortality attributed mainly to poor insulin access. Free insulin provision programs for people with type 1 diabetes have been introduced across Africa recently. We aimed to determine the mortality rate and associated factors in a cohort of children and adolescents with type 1 diabetes who receive free insulin treatment in sub-Saharan Africa. METHODS: We conducted a retrospective analysis using the Changing Diabetes in Children (CDiC) medical records in Cameroon between 2011 and 2015. RESULTS: The overall mortality rate was 33.0 per 1000 person-years (95% CI 25.2-43.2). Most deaths (71.7%) occurred outside of the hospital setting, and the cause of death was known only in 13/53 (24.5%). Mortality was substantially higher in CDiC participants followed up in regional clinics compared to the main urban CDiC clinic in Yaounde; 41 per 1000 years (95% CI 30.8-56.0) versus 17.5 per 1000 years (95% CI 9.4-32.5), and in those with no formal education compared to those who had some level of education; 68.0 per 1000 years (95% CI 45.1-102.2) versus 23.6 per 1000 years (95% CI 16.5-33.8). In Cox proportional multivariable analysis, urban place of care (HR = 0.23, 95% CI 0.09-0.57; p = 0.002) and formal education (HR = 0.42, 95% CI 0.22-0.79; p = 0.007) were independently associated with mortality. CONCLUSION: Despite free insulin provision, mortality remains high in children and adolescents with type 1 diabetes in Cameroon and is substantially higher in rural settings and those with no formal education.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.format.extent33-37
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 23, No. 1, pp. 33-37en_GB
dc.identifier.doihttps://doi.org/10.1111/pedi.13294
dc.identifier.grantnumber17/63/131en_GB
dc.identifier.urihttp://hdl.handle.net/10871/130989
dc.identifierORCID: 0000-0002-0883-7599 (Jones, Angus G)
dc.identifierScopusID: 7407101887 (Jones, Angus G)
dc.identifierORCID: 0000-0003-3559-6660 (McDonald, Timothy J)
dc.identifierScopusID: 54393616700 (McDonald, Timothy J)
dc.language.isoenen_GB
dc.publisherWileyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/34820965en_GB
dc.rights.embargoreasonUnder embargo until 20 January 2023 in compliance with publisher policyen_GB
dc.rightsCopyright © 2022 John Wiley & Sons, Inc. All rights reserveden_GB
dc.subjectCameroonen_GB
dc.subjectchanging diabetes in childrenen_GB
dc.subjectinsulin accessen_GB
dc.subjectmortalityen_GB
dc.subjecttype 1 diabetesen_GB
dc.titleMortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: The case study of the Changing Diabetes in Children program in Cameroon.en_GB
dc.typeArticleen_GB
dc.date.available2022-09-27T15:19:31Z
dc.identifier.issn1399-543X
exeter.place-of-publicationDenmark
dc.descriptionThis is the author accepted manuscript. The final version is available from Wiley via the DOI in this record en_GB
dc.descriptionData availability statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.en_GB
dc.identifier.eissn1399-5448
dc.identifier.journalPediatric Diabetesen_GB
dc.relation.ispartofPediatr Diabetes, 23(1)
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2021-11-15
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2022-01-20
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-09-27T14:47:17Z
refterms.versionFCDAM
refterms.panelAen_GB
refterms.dateFirstOnline2022-01-20


Files in this item

This item appears in the following Collection(s)

Show simple item record